MIRA
MIRA Pharmaceuticals, Inc.
1W: +3.9%
1M: -16.5%
3M: -33.3%
YTD: -28.9%
1Y: -13.1%
$1.06
-0.06 (-5.36%)
After Hours: $1.07 (+0.01, +1.42%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$44.4M
52W Range0.73-2.45
Volume112,395
Avg Volume152,111
Beta1.80
Dividend—
Analyst Ratings
Company Info
CEOErez Aminov
Employees2
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2023-08-14
Websitemirapharmaceuticals.com
855 North Wolfe Street
Baltimore, MD 21205
US
Baltimore, MD 21205
US
737-289-0835
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Latest News
What's Going On With MIRA Pharma Stock Tuesday?
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 29.4% in February
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Aminov Erez | A-Award | 3,155,170 | $1.45 | 2025-12-17 |
| Aminov Erez | M-Exempt | 234,595 | $1.16 | 2025-10-16 |
| Aminov Erez | M-Exempt | 379,000 | $0.84 | 2025-10-16 |
| Shekhat Denil Nanji | A-Award | 22,378 | $1.35 | 2025-10-01 |
| Aminov Erez | A-Award | 2,685,456 | — | 2025-10-01 |